Human DNA Vaccine Market Overview
The Human DNA Vaccine Market was valued at USD 3.5 billion in 2024 and is projected to reach USD 15 billion by 2035, growing at a CAGR of 14.2%. DNA vaccines represent a revolutionary approach to immunization, using genetically engineered plasmids to stimulate immune responses against infectious diseases, cancer, and genetic disorders. The market is segmented into therapeutic and prophylactic...
0 Commentaires 0 Parts 14 Vue 0 Aperçu